If you’re like me and have also pulled almost everything out of your fridge to find your go-to salad dressing or that one ...

Imugene has dosed the first Australian subject in a Phase Ib trial of its allogeneic CAR T-cell therapy, azer-cel (azercabtagene zapreleucel).

Imugene Ltd (ASX:IMU, OTC:IUGNF) has launched a Phase 1b clinical trial at the Royal Prince Alfred Hospital in Sydney, dosing the first Australian patient with its allogeneic CAR T-cell therapy ...

Imugene Limited (AU:IMU) has released an update.Don't Miss Our New Year's Offers:Discover the latest stocks recommended by top Wall Street ...

In a new book, a science journalist recounts the story of a lifesaving treatment for infection that scientists broadly ...

The proposed transaction will create a Nasdaq-traded, biotechnology company with product candidates in advanced stages of clinical development and a focus on advancing its allogeneic cell therapy plat ...

bilkul satta king Progress and challenges of stem cell therapy in some central nervous system diseases Chinese herbal medicine pieces can be sold on the shelf Important discovery of Nature Medicine: ...